Digital therapeutics

News round-up by DDW’s Reece Armstrong for 23-27 May   UK investment plans, company appointments to drive strategy, and digital health platforms are some of the themes of this week’s news round-up.    New £20m fund launches to support North West life sciences  A new £20 million fund has been launched in the Northwest of England to […]

Digital therapeutics provider Sidekick Health has launched an integrated solution for improving the outcomes of patients with Atopic Dermatitis (AD). The product was developed in collaboration with Pfizer and will be rolled out in the UK first before being launched in other regions.   The launch marks the next phase of a growing relationship to develop […]

Digital therapy company Sidekick Health has raised $55 million in Series B funding to help it expand its business. The round was led by London-based venture capital firm Novator Ventures, with additional participation from Wellington Partners, Asabys Partners, and Frumtak Ventures, as well as a US-based strategic investor.    Sidekick is developing personalised digital therapeutics that […]

The last patient has completed a clinical trial investigating the use of a digital platform to help patients with hypertension personalise and optimise their therapy regime. The PERSONAL COVID BP clinical trial was organised by therapeutics company Closed Loop Medicine to assess the use of its smartphone app to monitor blood pressure in patients also […]

Digital therapeutics (DTx) uses digital technology to remotely prevent, treat, or manage a wide range of conditions through data-driven interventions; GlobalData says several opportunities exist in the digital therapeutics market for neurological diseases in Japan.  Shionogi & Co, a partner of Akili Interactive, a prescription digital medicine company of PureTech Health, has announced topline results of a […]